Viewing Study NCT00258895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-27 @ 11:40 PM
Study NCT ID: NCT00258895
Status: COMPLETED
Last Update Posted: 2016-04-14
First Post: 2005-11-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diphtheria View
None Tetanus View
None Pertussis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DAPTACEL® View
None Pentacel™ View
None Diphtheria View
None Tetanus View
None Pertussis View
None Whooping cough View
None Acellular Pertussis Vaccine Adsorbed View